Taiwan’s Executive Yuan Science & Technology Advisory Group recently published “Spotlight on Taiwan Bio-Industries”, which introduces various aspects of the Taiwan Biotechnology industry including global competitiveness, industry highlights, investment incentives and more.
With the increasing number of biologics coming to market, the demand for drug delivery solutions such as auto injectors has increased significantly in recent years. This demand is projected to grow even more rapidly in the next five years. While North America and Europe have been key drivers for such devices, the trend of launching more combination products has already begun to influence other regions such as Asia. As a result, events such as The World Drug Delivery Congress 2011 in Singapore will attract the attention of biopharmaceutical companies, drug delivery device manufacturers and more
In an agreement facilitated by the Indiana Economic Development Corporation (IEDC) during a February economic mission to India, the Indiana Clinical and Translational Sciences Institute (CTSI) has partnered with GVK Biosciences, Asia’s leading contract research organisation, to provide researchers across the United States access to GVK BIO’s Clinical Biomarker Database that will advance research on wide range of diseases.
Familiarity breeds contempt, it's said, but not in the case of GlaxoSmithKline's most recent tool for SAR analysis: Helium, which has the ubiquitous Microsoft Excel at its core, and received Bio-IT World's Best Practices Award in the Knowledge Management category this year.
The winner of the Malvern Instruments £250 prize for the best student poster presented at the recent UK Colloids 2011 conference was Thakshila Balasuriya from The University of Melbourne, for her work describing ‘Dynamic Forces between Bubbles with Switchable Peptide Surfactants’. Thakshila is a third year PhD student in the Dynamic Interfacial Forces Group and her thesis work is focused on nanoscale interactions forces in biomolecular systems in soft matter.
Malvern Instruments has released a new version of software for the company’s Morphologi G3 particle characterization system. This fully automated image analysis-based system delivers particle size and shape information for wet and dry samples, and for the analysis of foreign particulate matter collected on filters. Among the new applications in the version 7.40 software are facilities for user-defined light settings and automated dark-field measurements, further extending the range of applications for which the Morphologi G3 can be used. A new reanalyze function enables the application of filters, classes and the rebinning of data to multiple records, for improved productivity and workflow.
The DASGIP iApp for remote control of DASGIP Parallel Bioreactor Systems now additionally includes webcam support. The upgraded DASGIP iApp version has been approved by Apple and is available for iPhone, iPad and iPod touch via the App store.
"Good value and excellent performance is a combination that will warm the heart of any academic polymer scientist,” said Professor Kenneth J Wynne of the Department of Chemical and Life Science Engineering at Virginia Commonwealth University, when asked about his 11-year use of Viscotek gel permeation chromatography (GPC) systems from Malvern Instruments.
Malvern Instruments Ltd (Malvern, UK) and Paraytec Ltd (York, UK) have entered into a development and licensing agreement that will see Paraytec’s ActiPix® technology being added to Malvern’s materials characterization portfolio. The agreement will give Malvern exclusive rights to further develop, market and sell ActiPix® UV area imaging technology in specific fields of use related to the characterization of complex fluids for applications in biopharmaceuticals, foods and personal care industrial sectors.
Join us from 25 - 27 October in Messe Frankfurt, Germany for CPhI Worldwide 2011, the world's leading pharmaceutical networking event with 28,500 attendees from 140 countries.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.